Rotman Research Institute at Baycrest
13
4
5
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 85/100
23.1%
3 terminated/withdrawn out of 13 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Impact of a Cognitive Intervention Enriched With Leisure Activities in Persons With Subjective Cognitive Decline
Role: collaborator
Accelerated Neuromodulation of Anterior Cingulate Cortex for Depression
Role: lead
Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory Problems
Role: lead
Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults
Role: lead
dTMS for Subjective Cognitive Decline
Role: lead
Effects of PSAPs on Speech Processing
Role: lead
Spaced Retrieval as Treatment for Aphasia
Role: lead
Lifestyle, Exercise and Diet: The LEAD Study
Role: lead
Effects of Intravenous (IV) Citalopram on Emotional Brain Activity in Healthy Young and Elderly Adults
Role: lead
Cognitive Reserve and Second Language Acquisition
Role: lead
Short-term Cognitive Training in Late-life Depression
Role: lead
Cognitive Rehabilitation in Patients With Spina Bifida
Role: collaborator
Cognitive Activation Therapy for MCI: A Randomized Control Study
Role: lead
All 13 trials loaded